[1]
K. Łobejko, K. Mitosek-Szewczyk, J. Kurzepa, J. Berbecki, and Z. Stelmasiak, “Bilirubin and uric acid serum levels in patients with relapsing-remitting multiple sclerosis after the first phase of cladribine treatment”, Curr. Issues Pharm. Med. Sci., vol. 23, no. 1, pp. 137–142, Apr. 2025, Accessed: Aug. 17, 2025. [Online]. Available: https://czasopisma.umlub.pl/curipms/article/view/2855